🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Completed
Location
Bellus Health Investigational Site #28
Start Date
2020-12-09
Trial ID
NCT04693195
This is a single-centre, open-label, non-randomised, single-period, single-...
Status
Completed
Location
Quotient Sciences
Start Date
2020-08-25
Trial ID
NCT05244759
Treatments Being Tested
This is a Phase I, Double-Blind, Randomised, Adaptive-designed Study to Ass...
Status
Completed
Location
Richmond Pharmacology Ltd.
Start Date
2021-08-06
Trial ID
NCT06179537
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-11-21
Trial ID
NCT07650084
This is a Phase 1, Single-Centre, Open-Label, Two-Part, Sequential Cross-Ov...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-07
Trial ID
NCT05570539
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2022-12-05
Trial ID
NCT05600777
This is a phase 1, 2-part, open-label, fixed-sequence study evaluating pote...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-07-26
Trial ID
NCT05959447
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase...
Status
Completed
Location
Phoenix Medical Research Inc
Start Date
2020-12-07
Trial ID
NCT04678206
This is a first-in-human study that will investigate the safety, tolerabili...
Status
Completed
Location
Alta Sciences Algorithme Pharma
Start Date
2018-07-09
Trial ID
NCT03638180
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-25
Trial ID
NCT05599191